• Posted On Saturday, July 10, 2021 by Evan Lamolinara

    Pharma Q2 2021 (1)

    SalesLeads announced today the Q2 2021 results for the new planned capital project spending report for the Pharmaceutical and BioTech industry. The Firm tracks North American planned industrial capital project activity including facility expansions, new plant construction and significant equipment modernization projects. Research confirms 103 new projects in the Pharmaceutical sector.

    Planned industrial project activity within the sector is up 18% YTD over the previous year.

    The following are selected highlights on new Pharmaceutical industry construction news.

    Pharmaceutical - By Project Type

              Manufacturing/Processing Facilities - 77 New Projects

              Laboratory Facilities - 21 New Projects

              Distribution and Industrial Warehouse - 15 New Projects

    Pharmaceutical - By Project Scope/Activity

              New Construction - 35 New Projects

              Expansion - 26 New Projects

              Renovations/Equipment Upgrades - 44 New Projects

              Plant Closing - 5 New Projects

    Pharmaceutical - By Project Location (Top 5 States)

              California - 11

              Pennsylvania - 7

              Massachusetts- 6

              North Carolina - 6

              New York - 6

    Largest Planned Project

    During the 2nd quarter of 2021, our research team identified 12 new Pharmaceutical facility construction projects with an estimated value of $100 million or more.

    The largest project is owned by Sanofi Pasteur, who is planning to invest $925 million for the construction of a processing facility in TORONTO, ON.

    Top 5 Tracked Pharmaceutical Projects

    NEW YORK:

    Biotechnology company is planning to invest $480 million for the expansion of their laboratory and processing facility in TARRYTOWN, NY by 207,000 sf.

    OHIO:

    Biotechnology company is planning to invest $365 million for the construction of a 270,000 sf processing facility in NEW ALBANY, OH. Construction is expected to start in Fall 2021.

    TENNESSEE:

    Specialty pharmaceutical products mfr. is planning to invest $220 million for the construction of a manufacturing facility in ORLINDA, TN.

    NORTH CAROLINA:

    Biotechnology company is planning to invest $213 million for the renovation and equipment upgrades on a 117,000 sf processing facility in SANFORD, NC.

    TEXAS:

    Biotechnology company is planning to invest $140 million for the construction of a processing facility in COLLEGE STATION, TX. They are currently seeking approval for the project.

     

    Since 1959, SalesLeads, based out of Jacksonville, FL has been providing Industrial Project Reports on companies that are planning significant capital investments in their industrial facilities throughout North America. Our professional research team identifies new construction, expansion, relocation, major renovation, equipment upgrades, and plant closing project opportunities so that our clients can focus sales and marketing resources on the target accounts that have an impending need for their products, services, and indirect materials.

    Each month, our team provides hundreds of industrial reports within a variety of industries, including:


    Comment